Experiences in growing a skin radiation therapy practice

G. Fogarty, D. Christie, B. Wong, E. Sim, Evan Ng, I. Porter, Tuna Ha, A. Potter
{"title":"Experiences in growing a skin radiation therapy practice","authors":"G. Fogarty, D. Christie, B. Wong, E. Sim, Evan Ng, I. Porter, Tuna Ha, A. Potter","doi":"10.15406/ijrrt.2020.07.00285","DOIUrl":null,"url":null,"abstract":"The successful treatment of skin disease decreases morbidity and mortality. Radiation therapy (RT) can cure skin disease and conserves tissue, possibly delivering better quality of life post treatment and so a superior survivorship. Modern RT delivers better dose conformality and homogeneity, and more is known about the radiobiology of skin and its diseases, enabling treatment personalisation. Skin, however, can be viewed in RT departments as not a serious subspecialty, even in Australia where the incidence of skin cancer is highest. Radiation oncology leaders are needed to carve out a niche for RT amongst a crowded field of skin carers. This article based on the cumulative experience of a group of Australian skin radiation oncologists (ROs), details how this may be achieved. First, focus is placed on growing a high-quality service. The RO needs to understand how patient, tumour and treatment factors impact the skin RT prescription. The particular nuances around skin RT planning, including immobilisation, simulation, contouring and the advantages and disadvantages of each RT modality in skin, are important to know. How skin reacts to RT when the skin is the target and the importance of fractionation is essential knowledge. Second, the RO needs to understand the needs of the skin stakeholders. These include those in the department who look to them for leadership. It includes those outside the department, that is, patients and other skin carers who could be future colleagues and even referrers. Third, the RO needs to use much needed research as a way to bring the disparate skin caring community together through completing high-quality research to guide therapy and post-treatment care.","PeriodicalId":214028,"journal":{"name":"International Journal of Radiology & Radiation Therapy","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiology & Radiation Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/ijrrt.2020.07.00285","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

The successful treatment of skin disease decreases morbidity and mortality. Radiation therapy (RT) can cure skin disease and conserves tissue, possibly delivering better quality of life post treatment and so a superior survivorship. Modern RT delivers better dose conformality and homogeneity, and more is known about the radiobiology of skin and its diseases, enabling treatment personalisation. Skin, however, can be viewed in RT departments as not a serious subspecialty, even in Australia where the incidence of skin cancer is highest. Radiation oncology leaders are needed to carve out a niche for RT amongst a crowded field of skin carers. This article based on the cumulative experience of a group of Australian skin radiation oncologists (ROs), details how this may be achieved. First, focus is placed on growing a high-quality service. The RO needs to understand how patient, tumour and treatment factors impact the skin RT prescription. The particular nuances around skin RT planning, including immobilisation, simulation, contouring and the advantages and disadvantages of each RT modality in skin, are important to know. How skin reacts to RT when the skin is the target and the importance of fractionation is essential knowledge. Second, the RO needs to understand the needs of the skin stakeholders. These include those in the department who look to them for leadership. It includes those outside the department, that is, patients and other skin carers who could be future colleagues and even referrers. Third, the RO needs to use much needed research as a way to bring the disparate skin caring community together through completing high-quality research to guide therapy and post-treatment care.
有开展皮肤放射治疗实践的经验
皮肤病的成功治疗降低了发病率和死亡率。放射治疗(RT)可以治愈皮肤疾病并保存组织,可能提供更好的治疗后生活质量,因此生存率更高。现代放射治疗提供了更好的剂量一致性和均匀性,并且对皮肤及其疾病的放射生物学有了更多的了解,使治疗个性化。然而,即使在皮肤癌发病率最高的澳大利亚,皮肤在RT部门也不被视为一个严重的亚专科。放射肿瘤学的领导者需要在拥挤的皮肤护理领域中开辟一个RT的利基市场。本文基于一组澳大利亚皮肤放射肿瘤学家(ROs)的累积经验,详细介绍了如何实现这一目标。第一,重点是发展高质量的服务。RO需要了解患者、肿瘤和治疗因素如何影响皮肤RT处方。了解皮肤RT计划的具体细微差别,包括固定,模拟,轮廓以及每种RT方式在皮肤中的优缺点,都很重要。当皮肤是靶时,皮肤对RT的反应以及分离的重要性是必不可少的知识。其次,RO需要了解皮肤利益相关者的需求。这些人包括那些在部门里指望他们领导的人。它包括科室外的人,即患者和其他可能成为未来同事甚至转诊的皮肤护理人员。第三,RO需要将急需的研究作为一种方式,通过完成高质量的研究来指导治疗和治疗后护理,将不同的皮肤护理社区聚集在一起。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信